McKesson Corporation
MCK
Positions held
Your positionsMCK isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- McKesson operates in a stable and essential industry, providing critical medical distribution services that are less susceptible to economic downturns.
- Revenue increased by 9% compared to the prior quarter, reaching $105.4 billion.
- The company's recommendation is a 'buy' with a strong score of 62.00, indicating positive market sentiment.
- The company's earnings growth has declined by 17.6%, raising concerns about profitability.
- Gross margin decreased to 3.5%, down from 4.2% in the prior quarter, indicating potential cost pressures.
- The trailing P/E ratio stands at 24.54, which may suggest the stock is overvalued compared to its earnings growth.
Fundamentals
| Market cap | $108.46B | Enterprise value | $118.03B | Trailing P/E | 24.93 | Forward P/E | 18.43 |
| PEG | 1.71 | Price / book | -25.45 | Beta | 0.30 | Dividend yield | 0.40% |
| Revenue growth | 7.7% | Earnings growth | -17.6% | Gross margin | 3.6% | Operating margin | 1.3% |
| Profit margin | 1.1% | ROE | — | ROA | 4.7% | Debt / equity | — |
| Current ratio | 0.89 | Free cash flow | $6.80B | Analyst recommendation | buy | Mean target | $980.67 |
| 52w high | $999.00 | 52w low | $723.68 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $105.4B | $96.3B | $106.2B | $103.2B | $97.8B | — |
| Op margin | 1.3% | 2.3% | 1.6% | 1.4% | 1.1% | — |
| Net income | $614M | $1.7B | $1.2B | $1.1B | $784M | — |
| Gross margin | 3.5% | 4.2% | 3.5% | 3.4% | 3.4% | — |
| Gross profit | $3.7B | $4.0B | $3.7B | $3.5B | $3.3B | — |
| Operating income | $1.4B | $2.2B | $1.7B | $1.5B | $1.1B | — |
- Revenue +9% vs prior quarter ($105.4B vs $96.3B).
- Gross margin 3.5% (was 4.2% prior quarter).
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $403.4B | $359.1B | $309.0B | $276.7B | — |
| Op margin | 1.6% | 1.3% | 1.4% | 1.7% | — |
| Net income | $4.8B | $3.3B | $3.0B | $3.6B | — |
| Gross margin | 3.6% | 3.7% | 4.2% | 4.5% | — |
| Gross profit | $14.6B | $13.3B | $12.8B | $12.4B | — |
| Operating income | $6.5B | $4.8B | $4.2B | $4.6B | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?
2026-10-09 · Option Care Health (OPCH) Faces Legal Review Of Its Proposed Takeover
2026-10-09 · 1 Profitable Stock to Target This Week and 2 We Ignore
2026-10-09 · If You Invested $1000 in McKesson a Decade Ago, This is How Much It'd Be Worth Now
2026-10-09 · Option Care Health (OPCH) Stock May Be Undervalued Despite The $5.8 Billion Buyout
2026-10-08 · How AI Adoption Could Supercharge McKesson (MCK)
2026-10-08 · Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
2026-10-08 · Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
2026-10-08 · What Does CVS Health (CVS) Gain From Extending Its Drug Distribution Deals To 2032?
2026-10-07 · Here's Why McKesson (MCK) Fell More Than Broader Market
2026-10-07 · Option Care stock surges on McKesson's home-infusion bet
2026-10-07 · Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
Price (daily)
Full chart · RSI · MACD · patternsOn Trade and Ticker
- 2026-10-06 · Midday UpdateS&P 500 Hits Record; Constellation Energy, Marvell and Option Care Surge
- 2026-10-06 · Morning BriefFutures Rise as Yields and Oil Ease; Constellation Energy Jumps on Google Nuclear Deal
- 2026-10-06 · Closing WrapConstellation Energy and Google, Marvell's AI Forecast, Option Care, Constellation Brands